A revolutionary and non-invasive medical therapy to restore endogenous bioelectrical balance and promote well-being

REAC (Radio Electric Asymmetric Conveyer) is an innovative medical technology for neuromodulation and biomodulation. It is not a pharmacological therapy but utilizes extremely low-intensity radioelectric fields, conveyed asymmetrically through a specific probe (ACP - Asymmetric Conveyer Probe), to interact with and optimize the body's endogenous bioelectric activity (EBA).

Unlike many other techniques, REAC does not impose an external electric current on the body. Instead, it interacts with the bioelectric fields already present within the human body. The extremely low-intensity radiofrequency emission, focused by the asymmetric conveyer probe, induces microcurrents within the tissues ('autologous,' i.e., generated by the tissue itself). These modulated microcurrents help restore correct cellular bioelectric activity, thereby optimizing cellular communication, repair and regeneration processes, as well as nervous system functionality.

The fundamental difference lies in the mechanism:

• REAC vs. Electrotherapy/tDCS/CES: These techniques apply an exogenous (external) electric current to the body via electrodes. REAC, however, does not directly apply current but uses a radioelectric field to induce and modulate endogenous (internal) microcurrents through interaction with the body's bioelectric activity, focused by the asymmetric probe.

• REAC vs. TMS (Transcranial Magnetic Stimulation): TMS uses powerful, brief magnetic fields to induce significant electric currents in the brain, primarily superficially at the cortex, aiming to directly excite or inhibit neurons. REAC uses extremely low-intensity radioelectric fields, theoretically has no depth limitations, and aims to optimize existing bioelectric activity rather than inducing strong depolarization.

• Overall Goal: REAC aims to optimize and reorganize endogenous bioelectric functionality, whereas many other techniques aim to directly excite or inhibit neuronal activity by imposing an external stimulus.

Based on the numerous studies provided, REAC technology is considered safe, non-invasive, and painless. No significant or serious adverse effects have been reported in the presented studies.

REAC Technology®, through various specific protocols (e.g., NPO, NPPO, TO-RPR, ACT, CO, MO), has demonstrated efficacy across a wide range of conditions, including:

• Stress-related disorders, anxiety, depression, bipolar disorder.

• Psychophysiological disorders (PPD) and medically unexplained physical symptoms.

• Chronic pain management.

• Musculoskeletal injuries (muscle tears, tendinitis, ligament injuries).

• Post-traumatic and post-surgical recovery (e.g., skin necrosis, wound healing).

• Ulcer healing (pressure ulcers, venous ulcers).

• Functional Dysmetria (FD) and improvement of motor and postural control.

• Symptoms associated with neurodegenerative diseases (Alzheimer's, Parkinson's, ALS - FAS variant) to improve motor, cognitive, and behavioral function, and quality of life.

• Autism Spectrum Disorder (ASD) for improving functional abilities.

• Conditions related to aging and cellular senescence.

• Inflammatory and metabolic conditions (e.g., management of metabolic syndrome, fibromyalgia, lipedema, cirrhosis).

REAC treatment is generally painless. Depending on the specific protocol, a probe (either punctiform or planar) is applied to targeted areas of the body (such as the auricle for NPO/NPPO or the specific treatment area for TO-RPR). The patient typically does not feel any particular sensation during the brief application of the radiofrequency impulses.

The duration varies significantly depending on the specific protocol:

• Neuro Postural Optimization (NPO): Consists of a single session involving a single impulse lasting only a few milliseconds (e.g., 250 ms).

• Neuro Psycho Physical Optimization (NPPO): Typically involves a cycle of 18 sessions. Each session lasts only a few seconds (e.g., 3-5 seconds), usually administered on alternate days over approximately 4-6 weeks.

• Tissue Optimization (TO-RPR, ACT, CO, MO): Usually involves cycles of 12-18 sessions. Each session lasts several minutes (e.g., 15 minutes). Sessions might be administered multiple times a day for shorter periods (e.g., 5-6 consecutive days for acute injury) or spread over several weeks.

The numerous studies provided document the efficacy of various REAC protocols across diverse conditions. Efficacy has been measured through:

• Psychometric assessments (e.g., significant reductions in PSM, DASS-42, HAM-D, NPI scores).

• Clinical and functional evaluations (e.g., resolution of Functional Dysmetria, improved mobility, performance on motor tests like FTSST, TUG).

• Imaging studies (e.g., visible lesion healing via ultrasound or MRI, documented changes in brain activation patterns on fMRI).

• Quality of Life improvements (measured by validated questionnaires like SF-12, FIQ, PedsQL).

• Cellular studies (demonstrating effects like induction of neuronal differentiation and anti-senescence properties).
  Results frequently show statistically significant improvements compared to baseline or control groups (placebo or standard treatments where applicable).

The duration of effects appears variable depending on the protocol and condition. NPO treatment has demonstrated remarkable long-lasting effects on the correction of Functional Dysmetria, with stability reported for up to 18 years in one longitudinal study. For other protocols like NPPO or TO, positive effects are often sustained over time following the treatment cycle. However, particularly for chronic or degenerative conditions, subsequent treatment cycles may be beneficial to consolidate or maintain results. The overall aim is typically to achieve stable and durable improvements.